JP2011502113A5 - - Google Patents

Download PDF

Info

Publication number
JP2011502113A5
JP2011502113A5 JP2010530588A JP2010530588A JP2011502113A5 JP 2011502113 A5 JP2011502113 A5 JP 2011502113A5 JP 2010530588 A JP2010530588 A JP 2010530588A JP 2010530588 A JP2010530588 A JP 2010530588A JP 2011502113 A5 JP2011502113 A5 JP 2011502113A5
Authority
JP
Japan
Prior art keywords
compound
group
administering
animal
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010530588A
Other languages
English (en)
Japanese (ja)
Other versions
JP5575651B2 (ja
JP2011502113A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2008/003666 external-priority patent/WO2009056983A1/en
Publication of JP2011502113A publication Critical patent/JP2011502113A/ja
Publication of JP2011502113A5 publication Critical patent/JP2011502113A5/ja
Application granted granted Critical
Publication of JP5575651B2 publication Critical patent/JP5575651B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010530588A 2007-10-31 2008-10-30 新規のｄｈａ誘導体およびその医薬品としての用途 Expired - Fee Related JP5575651B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US109707P 2007-10-31 2007-10-31
US61/001,097 2007-10-31
PCT/IB2008/003666 WO2009056983A1 (en) 2007-10-31 2008-10-30 New dha derivatives and their use as medicaments

Publications (3)

Publication Number Publication Date
JP2011502113A JP2011502113A (ja) 2011-01-20
JP2011502113A5 true JP2011502113A5 (https=) 2011-12-15
JP5575651B2 JP5575651B2 (ja) 2014-08-20

Family

ID=40374914

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010530588A Expired - Fee Related JP5575651B2 (ja) 2007-10-31 2008-10-30 新規のｄｈａ誘導体およびその医薬品としての用途

Country Status (5)

Country Link
US (1) US20100267828A1 (https=)
EP (1) EP2217558A1 (https=)
JP (1) JP5575651B2 (https=)
KR (1) KR20100100818A (https=)
WO (1) WO2009056983A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2248798A1 (en) * 2009-05-08 2010-11-10 Pronova BioPharma Norge AS Novel lipid compounds
SG175401A1 (en) * 2009-05-08 2011-12-29 Pronova Biopharma Norge As Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
MY170076A (en) 2010-11-05 2019-07-03 Pronova Biopharma Norge As Methods of treatment using lipid compounds
US9340483B2 (en) 2012-02-15 2016-05-17 Anida Pharma Inc. Methods of treating amyotrophic lateral sclerosis
WO2014132134A1 (en) 2013-02-28 2014-09-04 Pronova Biopharma Norge As A composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same
BR112017023164A2 (en) 2015-04-28 2018-07-24 Pronova Biopharma Norge As and method of preventing and / or treating non-alcoholic steatohepatitis in an individual in need thereof
CA3005983A1 (en) 2015-11-23 2017-06-01 Retrotope, Inc. Site-specific isotopic labeling of 1,4-diene systems
HRP20241643T1 (hr) 2017-12-06 2025-02-14 Basf As Derivati masnih kiselina za liječenje nealkoholnog steatohepatitisa
CA3172351A1 (en) 2020-02-21 2021-08-26 Retrotope, Inc. Processes for isotopic modification of polyunsaturated fatty acids and derivatives thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2836628A (en) * 1955-10-17 1958-05-27 Monsanto Chemicals Unsaturated branched-chain alcohols and methods of preparing same
US4132719A (en) * 1978-04-20 1979-01-02 Mcneilab Inc. Dibromoalkylglycidic acid derivatives
US4264517A (en) * 1978-12-11 1981-04-28 G.D. Searle & Co. Alkylphenyl 5Z,8Z,11Z,14Z,17Z-eicosapentaenoates
US4647685A (en) * 1985-04-25 1987-03-03 Eli Lilly And Company 2-alkoxy-1-((2-trialkylaminoethoxy)phosphinyloxy)-alkenes and alkynes, hydroxy inner salts
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
US5422371A (en) * 1992-05-27 1995-06-06 Arch Development Corp. Methods and compositions for inhibiting 5α-reductase activity
JPH0692848A (ja) * 1992-09-11 1994-04-05 Sagami Chem Res Center 糖尿病治療用乳剤
JPH06192177A (ja) * 1992-10-27 1994-07-12 Sando Yakuhin Kk グリセリン誘導体並びにこれを含有する血小板凝集抑制剤および脂肪輸液剤
WO1999058120A1 (en) * 1998-05-08 1999-11-18 Rolf Berge USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS
GB9901809D0 (en) * 1999-01-27 1999-03-17 Scarista Limited Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes
JP4530311B2 (ja) * 2000-07-13 2010-08-25 日本水産株式会社 リパーゼを用いたグリセライドの製造方法
JP2002180082A (ja) * 2000-12-11 2002-06-26 Maruha Corp 摂取物
US20040235948A1 (en) * 2003-03-05 2004-11-25 Solvay Pharmaceuticals Gmbh Treatment of diabetic patients with omega-3-fatty acids
KR101362989B1 (ko) * 2003-03-27 2014-02-17 산토리 홀딩스 가부시키가이샤 지질 개선제 및 지질 개선제를 함유하는 조성물
US20060135610A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Cardiovascular compositions
US20060183174A1 (en) * 2005-02-11 2006-08-17 Leong Ng Diagnosis
JP2008540394A (ja) * 2005-05-04 2008-11-20 プロノヴァ バイオファーマ ノルゲ アクティーゼルスカブ 脂肪酸組成物、即ち、ｄｈａ誘導体の医薬としての使用
KR101438177B1 (ko) * 2006-11-01 2014-09-05 프로노바 바이오파마 너지 에이에스 페록시솜 증식자-활성화 수용체의 활성자 또는 조절자인 알파-치환된 오메가-3 지질
RU2009120568A (ru) * 2006-11-01 2010-12-10 Пронова Биофарма Норге Ас (No) Композиция

Similar Documents

Publication Publication Date Title
JP2011502113A5 (https=)
US11685735B2 (en) Pharmaceutical composition comprising berberine salts for the treatment of various diseases or disorders
JP6986022B2 (ja) Ｆｘｒアゴニストを使用するための方法
CN106715456B (zh) 定向淋巴的前药
US10258609B2 (en) Therapeutic agent for dyslipidemia
RU2009120534A (ru) Новые липидные соединения
BR112020011431A2 (pt) derivados de ácido graxo para o tratamento de esteato-hepatite não alcoólica
JP2010508262A5 (https=)
JP5575651B2 (ja) 新規のｄｈａ誘導体およびその医薬品としての用途
KR20130132836A (ko) 지질 화합물을 이용한 치료방법
CN1159305C (zh) 新的2-(n-氰基亚氨基)噻唑烷-4-酮衍生物
RU2008141907A (ru) Конъюгированные липидные производные
CN101652134B (zh) 用于预防和/或治疗脂肪肝或非酒精性脂肪性肝炎的药物
US20230348457A1 (en) Berberine salts, ursodeoxycholic salts and combinations, methods of preparation and application thereof
CN1466465A (zh) 肥胖或脂肪肝的预防或治疗药物
JP2010513534A (ja) Ｍｔｐインヒビターおよびコレステロール吸収インヒビターを含む組み合わせを用いて肥満症を処置する方法
JP2019518738A (ja) 組成物、ならびにその適用および薬学的調製の方法
CN1173705C (zh) β－2－羟甲基－5－(5－氟胞嘧啶－1－基)－1,3－噁噻戊环在制药中的应用及含有该化合物的药物组合物
JP2008530242A5 (https=)
JP6650006B2 (ja) 脂質異常症治療剤
US20250002490A1 (en) Berberine salts, ursodeoxycholic salts and combinations, methods of preparation and application thereof
JP2022523792A (ja) 肥満及び関連する障害の予防及び治療のための化合物
WO2003004484A1 (en) Novel aliphatic compounds, synthesis method and method of using the same
HK40100604A (zh) 定向淋巴的前药
HK40100603A (zh) 定向淋巴的前药